
A Strategy for Rescheduling Psilocybin
There are three legal pathways to deregulating the drug under the Controlled Substances Act
Mason Marks is an assistant professor of law at the University of New Hampshire Franklin Pierce School of Law. He is a senior fellow and project lead of the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. In 2021, Governor Kate Brown appointed him to the Oregon Psilocybin Advisory Board, which advises the Oregon Health Authority on rules for the state's emerging psilocybin industry.
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account